Quantcast

Bevacizumab and AZD2171 (cediranib), Phase 1 trial Results


#1

One patient with synovial sarcoma experienced partial remission in this phase 1 trial:

http://www.ncbi.nlm.nih.gov/pubmed/24752867

Unfortunately, there's no trial open with this combination at the moment :-(